Cargando…

The Ketogenic Diet for the Treatment of Mood Disorders in Comorbidity With Epilepsy in Children and Adolescents

The ketogenic diet, used for over a century as an alternative therapy for the control of drug-resistant seizures in both children and adults, has recently drawn increasing interest in various neurological or psychiatric disorders other than epilepsy. In particular, there are a few preliminary studie...

Descripción completa

Detalles Bibliográficos
Autores principales: Operto, Francesca Felicia, Matricardi, Sara, Pastorino, Grazia Maria Giovanna, Verrotti, Alberto, Coppola, Giangennaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768824/
https://www.ncbi.nlm.nih.gov/pubmed/33381032
http://dx.doi.org/10.3389/fphar.2020.578396
_version_ 1783629216422559744
author Operto, Francesca Felicia
Matricardi, Sara
Pastorino, Grazia Maria Giovanna
Verrotti, Alberto
Coppola, Giangennaro
author_facet Operto, Francesca Felicia
Matricardi, Sara
Pastorino, Grazia Maria Giovanna
Verrotti, Alberto
Coppola, Giangennaro
author_sort Operto, Francesca Felicia
collection PubMed
description The ketogenic diet, used for over a century as an alternative therapy for the control of drug-resistant seizures in both children and adults, has recently drawn increasing interest in various neurological or psychiatric disorders other than epilepsy. In particular, there are a few preliminary studies in mood and neurodevelopmental disorders such as anxiety, depression and autism spectrum disorders. Mood disorders in comorbidity with epilepsy are commonly seen in adolescents and young adults both at the onset and during the course of the epileptic disorder. The rationale for the use of the ketogenic diet is based on the potential mood stabilizing effects through level modifications of metabolites such as dopamine and serotonin and the regulation of GABA/glutamatergic neurotransmission, mitochondrial function and oxidative stress. In this review, epilepsies with a higher risk of mood disorders in adolescents will be considered. A brief overview of the various types of ketogenic diet that can currently be offered to young patients in order to improve palatability and compliance with the diet, is also included. The efficacy and tolerability of the ketogenic diet options for the treatment of mood disorders, with or without drug therapy including mood stabilizers and antidepressant drugs, are as well discussed.
format Online
Article
Text
id pubmed-7768824
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-77688242020-12-29 The Ketogenic Diet for the Treatment of Mood Disorders in Comorbidity With Epilepsy in Children and Adolescents Operto, Francesca Felicia Matricardi, Sara Pastorino, Grazia Maria Giovanna Verrotti, Alberto Coppola, Giangennaro Front Pharmacol Pharmacology The ketogenic diet, used for over a century as an alternative therapy for the control of drug-resistant seizures in both children and adults, has recently drawn increasing interest in various neurological or psychiatric disorders other than epilepsy. In particular, there are a few preliminary studies in mood and neurodevelopmental disorders such as anxiety, depression and autism spectrum disorders. Mood disorders in comorbidity with epilepsy are commonly seen in adolescents and young adults both at the onset and during the course of the epileptic disorder. The rationale for the use of the ketogenic diet is based on the potential mood stabilizing effects through level modifications of metabolites such as dopamine and serotonin and the regulation of GABA/glutamatergic neurotransmission, mitochondrial function and oxidative stress. In this review, epilepsies with a higher risk of mood disorders in adolescents will be considered. A brief overview of the various types of ketogenic diet that can currently be offered to young patients in order to improve palatability and compliance with the diet, is also included. The efficacy and tolerability of the ketogenic diet options for the treatment of mood disorders, with or without drug therapy including mood stabilizers and antidepressant drugs, are as well discussed. Frontiers Media S.A. 2020-11-24 /pmc/articles/PMC7768824/ /pubmed/33381032 http://dx.doi.org/10.3389/fphar.2020.578396 Text en Copyright © 2020 Operto, Matricardi, Pastorino, Verrotti and Coppola http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Operto, Francesca Felicia
Matricardi, Sara
Pastorino, Grazia Maria Giovanna
Verrotti, Alberto
Coppola, Giangennaro
The Ketogenic Diet for the Treatment of Mood Disorders in Comorbidity With Epilepsy in Children and Adolescents
title The Ketogenic Diet for the Treatment of Mood Disorders in Comorbidity With Epilepsy in Children and Adolescents
title_full The Ketogenic Diet for the Treatment of Mood Disorders in Comorbidity With Epilepsy in Children and Adolescents
title_fullStr The Ketogenic Diet for the Treatment of Mood Disorders in Comorbidity With Epilepsy in Children and Adolescents
title_full_unstemmed The Ketogenic Diet for the Treatment of Mood Disorders in Comorbidity With Epilepsy in Children and Adolescents
title_short The Ketogenic Diet for the Treatment of Mood Disorders in Comorbidity With Epilepsy in Children and Adolescents
title_sort ketogenic diet for the treatment of mood disorders in comorbidity with epilepsy in children and adolescents
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768824/
https://www.ncbi.nlm.nih.gov/pubmed/33381032
http://dx.doi.org/10.3389/fphar.2020.578396
work_keys_str_mv AT opertofrancescafelicia theketogenicdietforthetreatmentofmooddisordersincomorbiditywithepilepsyinchildrenandadolescents
AT matricardisara theketogenicdietforthetreatmentofmooddisordersincomorbiditywithepilepsyinchildrenandadolescents
AT pastorinograziamariagiovanna theketogenicdietforthetreatmentofmooddisordersincomorbiditywithepilepsyinchildrenandadolescents
AT verrottialberto theketogenicdietforthetreatmentofmooddisordersincomorbiditywithepilepsyinchildrenandadolescents
AT coppolagiangennaro theketogenicdietforthetreatmentofmooddisordersincomorbiditywithepilepsyinchildrenandadolescents
AT opertofrancescafelicia ketogenicdietforthetreatmentofmooddisordersincomorbiditywithepilepsyinchildrenandadolescents
AT matricardisara ketogenicdietforthetreatmentofmooddisordersincomorbiditywithepilepsyinchildrenandadolescents
AT pastorinograziamariagiovanna ketogenicdietforthetreatmentofmooddisordersincomorbiditywithepilepsyinchildrenandadolescents
AT verrottialberto ketogenicdietforthetreatmentofmooddisordersincomorbiditywithepilepsyinchildrenandadolescents
AT coppolagiangennaro ketogenicdietforthetreatmentofmooddisordersincomorbiditywithepilepsyinchildrenandadolescents